4
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Preliminary Study of Indocyanine Green Clearance in Primary Biliary Cirrhosis

, &
Pages 119-123 | Received 14 May 1990, Accepted 30 Jul 1990, Published online: 08 Jul 2009

References

  • Roll J, Boyer J L, Barry D, Klatskin G. The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308: 1–7
  • Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 1989; 24: 57–64
  • Christensen E, Neuberger J, Crowe J, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 1985; 89: 1084–1091
  • Esquivel C O, Van Thiel D H, Demetris A J, et al. Transplantation for primary biliary cirrhosis. G astro-enterology 1988; 94: 1207–1216
  • Keiding S, Ericzon B G, Eriksson S, et al. Survival after liver transplantation of patients with primary biliary cirrhosis in the Nordic countries. Scand J Gastroenterol 1990; 25: 11–18
  • Marcus B H, Dickson E R, Grambsch P M, et al. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989; 320: 1709–1713
  • Kirby R M, McMaster P, Clements D, et al. Ortho-topic liver transplantation: postoperative complications and their management. Br J Surg 1987; 24: 3–11
  • Shapiro J M, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20: 137–140
  • Dickson E R, Grambsch P M, Fleming T R, Fisher L D, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1–7
  • Babbs C, Smith A, Hunt L P, Rowan B P, Haboubi N Y, Warnes T W. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Lancet 1988; 1: 1021–1024
  • Bonsel G J, Klopmaker I J, Veer F V, Habbema J D F, Slooff M J H. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 1990; 1: 493–497
  • Grambsch P M, Dickson E R, Wiesner R H, Lang-Worthy A. Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. Mayo Clin Proc 1989; 64: 699–704
  • Neuberger J, Altman D G, Christensen E, Tygstrup N, Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation 1986; 41: 713–716
  • Neuberger J, Altman D G, Polson R, et al. Prognosis after liver transplantation for primary biliary cirrhosis. Transplantation 1989; 48: 444–447
  • Christensen E. Prognostication in primary biliary cirrhosis: relevance to the individual patient. Hepatology 1989; 10: 111–113
  • Clements D, McMaster P, Elias E. Indocyanine green clearance in acute rejection following liver transplantation. Transplantation 1988; 46: 383–385
  • Clements D, West R, Elias E. Comparison of bolus and infusion methods for estimating hepatic blood flow in patients with liver disease using indocyanine green. J Hepatol 1987; 5: 282–287
  • Kew M C, Varma R R, Dos Santos H A, Scheuer P J, Sherlock S. Portal hypertension in primary biliary cirrhosis. Gut 1971; 12: 830–834
  • Thornton J R, Triger D R, Losowsky M S. Variceal bleeding is associated with reduced risk of severe cholestasis in primary biliary cirrhosis. Q J Med 1989; 71: 467–471

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.